The Latin America, Middle East and Africa IVD In Cardiology And Neurology Market would witness market growth of 12.1% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA IVD In Cardiology And Neurology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $562.5 million by 2030. The Argentina market is showcasing a CAGR of 12.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.7% during (2023 - 2030).
Incorporating genomics into intravenous disease (IVD) tests facilitates accurate risk stratification, empowering medical professionals to detect individuals more susceptible to the onset of cardiovascular or neurological ailments. This information empowers clinicians to tailor preventive strategies, lifestyle recommendations, and therapeutic interventions based on an individual's genetic predispositions. Personalized treatment plans enhance the efficacy of interventions, leading to more targeted and efficient patient care.
Furthermore, liquid biopsy, a non-invasive diagnostic approach, is gaining traction in neurology. This innovative technique involves analyzing circulating biomarkers, such as DNA, RNA, or proteins, in the bloodstream. In neuro-oncology, liquid biopsy is promising for early cancer detection, treatment response monitoring, and minimal residual disease detection. By identifying specific genetic mutations or alterations associated with brain tumors, liquid biopsy enables clinicians to detect the presence of cancerous cells at an early stage. Early detection is crucial for timely interventions and improved patient outcomes.
Middle East has witnessed an increase in cardiovascular disease (CVD) cases over recent years. As per the National Library of Medicine, the Middle East has a high rate of cardiovascular disease (10.1%). In this region, the prevalence of dyslipidemia (43.3%) is double that of hypertension (26.2%) and diabetes mellitus (16%). Multifaceted interventions are desperately needed in this region for CVD primary prevention. Hence, the rising number of cardiovascular disease cases and healthcare sector growth in LAMEA will assist in the growth of the regional market.
Free Valuable Insights: The Worldwide IVD In Cardiology And Neurology Market is Projected to reach USD 29.9 Billion by 2030, at a CAGR of 9.3%
Based on Product Type, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. Based on End Use, the market is segmented into Hospitals, Clinical Laboratories, and Others. Based on Technology, the market is segmented into Immunoassays, Molecular Diagnostics, Hematology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Thermo Fisher Scientific, Inc.
- F.Hoffmann-La Roche Ltd.
- Sysmex Corporation
- Siemens Healthineers AG (Siemens AG)
- Quest Diagnostics Incorporated
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- Becton, Dickinson and Company
- Natera, Inc.
LAMEA IVD In Cardiology And Neurology Market Report Segmentation
By Product Type
- Reagents & Consumables
- Instruments
- Software & Services
By End Use
- Hospitals
- Clinical Laboratories
- Others
By Technology
- Immunoassays
- Molecular Diagnostics
- Hematology
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA IVD In Cardiology And Neurology Market, by Product Type
1.4.2 LAMEA IVD In Cardiology And Neurology Market, by End Use
1.4.3 LAMEA IVD In Cardiology And Neurology Market, by Technology
1.4.4 LAMEA IVD In Cardiology And Neurology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA IVD In Cardiology And Neurology Market by Product Type
4.1 LAMEA Reagents & Consumables Market by Country
4.2 LAMEA Instruments Market by Country
4.3 LAMEA Software & Services Market by Country
Chapter 5. LAMEA IVD In Cardiology And Neurology Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Clinical Laboratories Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA IVD In Cardiology And Neurology Market by Technology
6.1 LAMEA Immunoassays Market by Country
6.2 LAMEA Molecular Diagnostics Market by Country
6.3 LAMEA Hematology Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA IVD In Cardiology And Neurology Market by Country
7.1 Brazil IVD In Cardiology And Neurology Market
7.1.1 Brazil IVD In Cardiology And Neurology Market by Product Type
7.1.2 Brazil IVD In Cardiology And Neurology Market by End-use
7.1.3 Brazil IVD In Cardiology And Neurology Market by Technology
7.2 Argentina IVD In Cardiology And Neurology Market
7.2.1 Argentina IVD In Cardiology And Neurology Market by Product Type
7.2.2 Argentina IVD In Cardiology And Neurology Market by End-use
7.2.3 Argentina IVD In Cardiology And Neurology Market by Technology
7.3 UAE IVD In Cardiology And Neurology Market
7.3.1 UAE IVD In Cardiology And Neurology Market by Product Type
7.3.2 UAE IVD In Cardiology And Neurology Market by End-use
7.3.3 UAE IVD In Cardiology And Neurology Market by Technology
7.4 Saudi Arabia IVD In Cardiology And Neurology Market
7.4.1 Saudi Arabia IVD In Cardiology And Neurology Market by Product Type
7.4.2 Saudi Arabia IVD In Cardiology And Neurology Market by End-use
7.4.3 Saudi Arabia IVD In Cardiology And Neurology Market by Technology
7.5 South Africa IVD In Cardiology And Neurology Market
7.5.1 South Africa IVD In Cardiology And Neurology Market by Product Type
7.5.2 South Africa IVD In Cardiology And Neurology Market by End-use
7.5.3 South Africa IVD In Cardiology And Neurology Market by Technology
7.6 Nigeria IVD In Cardiology And Neurology Market
7.6.1 Nigeria IVD In Cardiology And Neurology Market by Product Type
7.6.2 Nigeria IVD In Cardiology And Neurology Market by End-use
7.6.3 Nigeria IVD In Cardiology And Neurology Market by Technology
7.7 Rest of LAMEA IVD In Cardiology And Neurology Market
7.7.1 Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type
7.7.2 Rest of LAMEA IVD In Cardiology And Neurology Market by End-use
7.7.3 Rest of LAMEA IVD In Cardiology And Neurology Market by Technology
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sysmex Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Siemens Healthineers AG (Siemens AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Quest Diagnostics Incorporated
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.5 SWOT Analysis
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Danaher Corporation (Beckman Coulter)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Becton, Dickinson, and Company
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
TABLE 1 LAMEA IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 2 LAMEA IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 3 LAMEA IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 4 LAMEA IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 5 LAMEA Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Reagents & Consumables Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Instruments Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Instruments Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 12 LAMEA IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 13 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 20 LAMEA IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 21 LAMEA Immunoassays Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Immunoassays Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Hematology Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Hematology Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA IVD In Cardiology And Neurology Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA IVD In Cardiology And Neurology Market by Country, 2023 - 2030, USD Million
TABLE 31 Brazil IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 32 Brazil IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 33 Brazil IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 34 Brazil IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 35 Brazil IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 36 Brazil IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 37 Brazil IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 38 Brazil IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 39 Argentina IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 40 Argentina IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 41 Argentina IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 42 Argentina IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 43 Argentina IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 44 Argentina IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 45 Argentina IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 46 Argentina IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 47 UAE IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 48 UAE IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 49 UAE IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 50 UAE IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 51 UAE IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 52 UAE IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 53 UAE IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 54 UAE IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 55 Saudi Arabia IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 63 South Africa IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 64 South Africa IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 65 South Africa IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 66 South Africa IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 67 South Africa IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 68 South Africa IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 69 South Africa IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 70 South Africa IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 71 Nigeria IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 72 Nigeria IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 73 Nigeria IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 74 Nigeria IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 75 Nigeria IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 76 Nigeria IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 77 Nigeria IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 78 Nigeria IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 79 Rest of LAMEA IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 89 Key Information – Sysmex Corporation
TABLE 90 Key Information – Siemens Healthineers AG
TABLE 91 Key information – Quest Diagnostics Incorporated
TABLE 92 Key Information – Abbott Laboratories
TABLE 93 Key Information – Bio-Rad Laboratories, Inc.
TABLE 94 Key Information – Danaher Corporation
TABLE 95 Key Information – Becton, Dickinson and Company
TABLE 96 Key Information – Natera Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA IVD In Cardiology And Neurology Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting IVD In Cardiology And Neurology Market
FIG 4 Porter’s Five Forces Analysis - IVD In Cardiology And Neurology Market
FIG 5 LAMEA IVD In Cardiology And Neurology Market share by Product Type, 2022
FIG 6 LAMEA IVD In Cardiology And Neurology Market share by Product Type, 2030
FIG 7 LAMEA IVD In Cardiology And Neurology Market by Product Type, 2019 - 2030, USD Million
FIG 8 LAMEA IVD In Cardiology And Neurology Market share by End-use, 2022
FIG 9 LAMEA IVD In Cardiology And Neurology Market share by End-use, 2030
FIG 10 LAMEA IVD In Cardiology And Neurology Market by End-use, 2019 - 2030, USD Million
FIG 11 LAMEA IVD In Cardiology And Neurology Market share by Technology, 2022
FIG 12 LAMEA IVD In Cardiology And Neurology Market share by Technology, 2030
FIG 13 LAMEA IVD In Cardiology And Neurology Market by Technology, 2019 - 2030, USD Million
FIG 14 LAMEA IVD In Cardiology And Neurology Market share by Country, 2022
FIG 15 LAMEA IVD In Cardiology And Neurology Market share by Country, 2030
FIG 16 LAMEA IVD In Cardiology And Neurology Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Sysmex Corporation
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 SWOT Analysis: Quest Diagnostics Incorporated
FIG 22 SWOT Analysis: Abbott Laboratories
FIG 23 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 24 SWOT Analysis: Danaher Corporation
FIG 25 SWOT Analysis: Becton, Dickinson and company
FIG 26 Swot Analysis: Natera, Inc.